ARZERRA 20 mg/mL

ARZERRA 20 mg/mL is an injectable solution containing ofatumumab, used for specific therapeutic purposes. This medication is administered intravenously and is available in single-use vials.

ARZERRA 20 mg/mL is primarily used in the treatment of certain types of chronic lymphocytic leukemia (CLL). This medication works by targeting specific cells in the body to help manage the condition. Patients often wonder, 'What is ARZERRA used for?' and it is typically prescribed for CLL when other treatments have not been effective.

Common effects of ARZERRA 20 mg/mL may include infusion reactions, which can range from mild to severe. These reactions typically occur during or shortly after the administration of the medication. Patients may also experience fatigue, fever, and chills. It is important to monitor for any signs of an allergic reaction.

ARZERRA 20 mg/mL should be handled with care and administered by a healthcare professional. It is crucial to follow the prescribed dosage and administration instructions. Patients with a history of severe allergic reactions to ofatumumab or any of the ingredients should avoid this medication. Always inform your healthcare provider about any existing medical conditions or medications you are taking.

ARZERRA 20 mg/mL may interact with other medications, including those that suppress the immune system. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain over-the-counter drugs may also affect the efficacy and safety of ARZERRA.